Donald Trump Orders Justice Department
to Investigate
Donald Trump Orders Justice Department
to Investigate Obama Surveillance < >
President Donald J. Trump announced his decision to demand an official investigation of former President Barack Obama’s administration on Sunday for infiltrating or surveilling his presidential campaign for political reasons.
“I hereby demand, and will do so officially tomorrow, that the Department of Justice look into whether or not the FBI/DOJ infiltrated or surveilled the Trump Campaign for Political Purposes – and if any such demands or requests were made by people within the Obama Administration!” Trump wrote on Twitter on Sunday afternoon.
Trump frequently blames investigations of his campaign on Obama, suggesting that politically motivated investigators were unfairly targeting his campaign.
He spent most of Sunday morning sharing his thoughts on Twitter about the ongoing Russia investigation, suggesting that the ongoing “witch hunt” was out of control. “Things are really getting ridiculous,” Trump wrote, noting that so far there was no collusion found by special investigators.
He criticized Special Counsel Robert Mueller’s team as “13 Angry and heavily conflicted Democrats” who were part of the Obama administration.
“STOP!” he wrote. “They have found no collusion with Russia, No obstruction.”
Trump again redirected the continuing investigation towards failed presidential candidate Hillary Clinton, Democrats, Tony Podesta, the DNC, and politically biased FBI officials.
“Republicans and real Americans should start getting tough on this Scam,” he wrote.
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Top 5 Most Recently Viewed Articles
Frutta Bowls Introduces a Seasonal Celebration with Pumpkin Spice As the fall season approaches, Frutta Bowls is delighted to unveil a new lineup of limited-time pumpkin spice menu items. Known for its creative acai bowls and wholesome smoothies, Frutta Bowls is bringing a delightful spin to a classic fall favorite. Fresh Take on a Seasonal Classic "Pumpkin spice has been...
Continue Reading
Transforming Clinical Data Management with Pinnacle 21 Enterprise Plus Certara, Inc. (Nasdaq: CERT), a leader in the field of biosimulation, has recently introduced a groundbreaking solution known as Pinnacle 21 Enterprise Plus. This innovative platform is designed to greatly enhance the process of preparing and managing necessary data specifications for clinical studies....
Continue Reading
Menlo Security hit the ground running back when it blasted past the $100 million annual recurring revenue (ARR) mark. That achievement ain’t just smoke and mirrors; it showed a hefty 50% growth over two years, snagging over 1,000 global enterprises and government agencies on its secure browsing ride. You bet traders were looking closely at those numbers, knowing they...
Continue Reading
What You Need to Know About the lululemon Securities Class Action If you've invested in lululemon athletica inc. (NASDAQ: LULU), it’s crucial to pay attention right now. A significant class action lawsuit is currently in progress, and time is running out. The Rosen Law Firm, known for its commitment to protecting investor rights, is reminding anyone who bought lululemon...
Continue Reading
Current Market Sentiment on SELLAS Life Sciences Group Inc SELLAS Life Sciences Group Inc (NYSE: SLS) is currently experiencing a notable increase in short interest, with a rise of 21.68% since the last report. This uptick reflects a current total of approximately 40.47 million shares sold short, which equates to roughly 28.62% of the total float available for trading....
Continue Reading